Racial Differences in Parkinson’s Disease Medication Use in the Reasons for Geographic and Racial Differences in Stroke Cohort: A Cross-Sectional Study
- 4 November 2009
- journal article
- research article
- Published by S. Karger AG in Neuroepidemiology
- Vol. 33 (4) , 329-334
Abstract
Background: Previous studies have suggested that African-American populations have a lower prevalence of Parkinson’s disease (PD); however, because African-Americans are underrepresented in many cohorts, this relationship is poorly understood. We evaluated data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study to describe potential racial differences in PD prevalence. Methods: We identified subjects using PD medications from the REGARDS study, a national longitudinal cohort study of 30,000 persons over age 45 with approximately equal representation of African-Americans and Whites. Results: The prevalence of PD medication use across the cohort was 0.78% and was less among African-Americans (0.51%) than among Whites (0.97%; OR 1.90; 95% CI 1.31–2.74). There was an association of gender and PD medication use, with a prevalence of 0.61% in females and 0.97% in males (OR 1.57; 95% CI 1.13–2.18). There was no association with income, education level or geographic region of residence. Conclusions: The lower rate of PD medication use among African-Americans supports the suspected lower prevalence of PD among African-Americans suggested by other studies. While racial differences in PD diagnosis and treatment may contribute to the differences we observed, comparable disparities have not been observed in the REGARDS cohort for other diagnoses. Further studies of the REGARDS cohort may lead to important insights into potential biological differences in PD among African-Americans and Whites.Keywords
This publication has 22 references indexed in Scilit:
- Race/Ethnicity and Nonadherence to Prescription Medications Among Seniors: Results of a National StudyJournal of General Internal Medicine, 2007
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studiesMovement Disorders, 2006
- Racial and Geographic Differences in Awareness, Treatment, and Control of HypertensionStroke, 2006
- The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and DesignNeuroepidemiology, 2005
- Disparities in Health Care: An OverviewAcademic Emergency Medicine, 2003
- Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy recordsPharmacoepidemiology and Drug Safety, 2001
- Parkinson’s disease and parkinsonism in a longitudinal studyNeurology, 2000
- Prevalence of Parkinson's disease in the biracial population of Copiah County, MississippiNeurology, 1985
- Occurrence of Parkinson's disease in black patients at Charity Hospital in New OrleansNeurology, 1974